Article
Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs*10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype.
Thrombosis research - 1 Jan 2021
Morrow Gael B, Beavis James, Harper Sarah, Bignell Patricia, Laffan Mike A, Curry Nicola
Abstract excerpt
INTRODUCTION: A novel variant in the thrombomodulin (TM) gene, c.1487delC,p.(Pro496Argfs*10), referred to as Pro496Argfs*10, was identified in a family with an unexplained bleeding disorder. The Pro496Argfs*10 variant results in loss of the transmembrane and intracellular segments of TM and is associated with an increase in soluble TM (sTM) in the plasma. The aim of this study was to characterise the effect of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
